PL1797112T3 - Inhibitory wirusa zapalenia wątroby typu C - Google Patents
Inhibitory wirusa zapalenia wątroby typu CInfo
- Publication number
- PL1797112T3 PL1797112T3 PL05814026T PL05814026T PL1797112T3 PL 1797112 T3 PL1797112 T3 PL 1797112T3 PL 05814026 T PL05814026 T PL 05814026T PL 05814026 T PL05814026 T PL 05814026T PL 1797112 T3 PL1797112 T3 PL 1797112T3
- Authority
- PL
- Poland
- Prior art keywords
- virus
- hepatitis
- present
- methods
- hepatitits
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 241000711549 Hepacivirus C Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 101800001473 Spike glycoprotein E2 Proteins 0.000 abstract 1
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000010710 hepatitis C virus infection Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61428004P | 2004-09-29 | 2004-09-29 | |
| EP05814026A EP1797112B1 (en) | 2004-09-29 | 2005-09-26 | Inhibitors of hepatitits c virus |
| PCT/US2005/034777 WO2006039326A2 (en) | 2004-09-29 | 2005-09-26 | Inhibitors of hepatitits c virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1797112T3 true PL1797112T3 (pl) | 2011-04-29 |
Family
ID=36143015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05814026T PL1797112T3 (pl) | 2004-09-29 | 2005-09-26 | Inhibitory wirusa zapalenia wątroby typu C |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7381705B2 (https=) |
| EP (1) | EP1797112B1 (https=) |
| JP (1) | JP4980915B2 (https=) |
| AT (1) | ATE474587T1 (https=) |
| AU (1) | AU2005292135B2 (https=) |
| CA (1) | CA2582095A1 (https=) |
| DE (1) | DE602005022463D1 (https=) |
| ES (1) | ES2349153T3 (https=) |
| PL (1) | PL1797112T3 (https=) |
| PT (1) | PT1797112E (https=) |
| WO (1) | WO2006039326A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009510122A (ja) * | 2005-09-29 | 2009-03-12 | ザ スクリプス リサーチ インスティテュート | ウイルスペプチドおよびフラビウイルス科のウイルスに対してウイルス感染を阻害するためのその使用 |
| WO2008124176A2 (en) | 2007-04-10 | 2008-10-16 | The Administrators Of The Tulane Educational Fund | Soluble and membrane-anchored forms of lassa virus subunit proteins |
| WO2009021063A2 (en) * | 2007-08-06 | 2009-02-12 | The Regents Of The University Of California | Composition and method of use for hcv immunization |
| WO2009030872A1 (en) * | 2007-09-07 | 2009-03-12 | Mats Axel Atterdag Persson | Materials and methods for the treatment of hepatitis c |
| CA2698666A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| US20100104555A1 (en) * | 2008-10-24 | 2010-04-29 | The Scripps Research Institute | HCV neutralizing epitopes |
| CA2658714A1 (en) | 2009-03-17 | 2010-09-17 | Thomas Krey | Hcv-derived polypeptides and uses thereof |
| WO2013050048A2 (en) | 2011-10-07 | 2013-04-11 | Skau Aps | Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped rna viruses |
| CN104324361A (zh) * | 2014-05-16 | 2015-02-04 | 中国疾病预防控制中心病毒病预防控制所 | 丙型肝炎病毒(hcv)细胞进入抑制肽zte2序列及应用 |
| CN109232721B (zh) * | 2018-09-26 | 2021-06-29 | 广州市第八人民医院 | Hcv包膜蛋白高度保守区域的肽段418-429及其用途 |
| AU2020323462A1 (en) * | 2019-07-26 | 2022-03-10 | The Scripps Research Institute | Engineered HCV E2 immunogens and related vaccine compositions |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0185373B1 (ko) * | 1989-03-17 | 1999-05-01 | 로버트 피. 블랙버언 | Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용 |
| US5747239A (en) * | 1990-02-16 | 1998-05-05 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines |
| EP0992580B1 (en) * | 1993-11-04 | 2005-03-09 | Innogenetics N.V. | Immunodominant human T-cell epitopes of Hepatitis C virus |
| US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| SE9503380D0 (sv) * | 1995-09-29 | 1995-09-29 | Pharmacia Ab | Protein derivatives |
| US6037348A (en) * | 1996-02-09 | 2000-03-14 | Eli Lilly And Company | Inhibition of viral replication |
| JP2001514508A (ja) * | 1997-03-05 | 2001-09-11 | ユニバーシティー オブ ワシントン | Ｃ型肝炎ウイルスの複製を選択的に抑制する薬剤を同定するための新規なスクリーニング法 |
| US6153421A (en) * | 1997-07-18 | 2000-11-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloned genomes of infectious hepatitis C viruses and uses thereof |
| US6127166A (en) * | 1997-11-03 | 2000-10-03 | Bayley; Hagan | Molluscan ligament polypeptides and genes encoding them |
| US7091324B2 (en) * | 1998-11-05 | 2006-08-15 | Board Of Trustees Of Leland Stanford Junior University | Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| EP1178116A1 (en) | 2000-08-03 | 2002-02-06 | Hybrigenics S.A. | Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| JP5175417B2 (ja) * | 2000-08-17 | 2013-04-03 | トリペップ アクチ ボラゲット | リバビリンを含むワクチンおよびその使用方法 |
| US20030232745A1 (en) * | 2001-06-26 | 2003-12-18 | Olson William C. | Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection |
| US7022323B2 (en) * | 2001-06-26 | 2006-04-04 | Progenics Pharmaceuticals, Inc. | Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| DK1558276T3 (da) | 2002-11-08 | 2012-10-22 | Univ Tulane | Flavivirus-fusionsinhibitorer |
| EP1638993A4 (en) * | 2003-06-10 | 2007-05-09 | Univ Melbourne | IMMUNOMODULATING COMPOSITIONS, APPLICATIONS THEREOF AND METHOD FOR THE PRODUCTION THEREOF |
-
2005
- 2005-09-26 AT AT05814026T patent/ATE474587T1/de not_active IP Right Cessation
- 2005-09-26 JP JP2007534728A patent/JP4980915B2/ja not_active Expired - Fee Related
- 2005-09-26 WO PCT/US2005/034777 patent/WO2006039326A2/en not_active Ceased
- 2005-09-26 ES ES05814026T patent/ES2349153T3/es active Active
- 2005-09-26 CA CA002582095A patent/CA2582095A1/en not_active Abandoned
- 2005-09-26 DE DE602005022463T patent/DE602005022463D1/de active Active
- 2005-09-26 EP EP05814026A patent/EP1797112B1/en not_active Not-in-force
- 2005-09-26 AU AU2005292135A patent/AU2005292135B2/en not_active Ceased
- 2005-09-26 PL PL05814026T patent/PL1797112T3/pl unknown
- 2005-09-26 US US11/235,672 patent/US7381705B2/en not_active Expired - Fee Related
- 2005-09-26 PT PT05814026T patent/PT1797112E/pt unknown
-
2008
- 2008-05-19 US US12/152,964 patent/US20080241156A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060069027A1 (en) | 2006-03-30 |
| JP2008514717A (ja) | 2008-05-08 |
| AU2005292135B2 (en) | 2011-09-29 |
| EP1797112A4 (en) | 2009-04-01 |
| EP1797112B1 (en) | 2010-07-21 |
| ATE474587T1 (de) | 2010-08-15 |
| AU2005292135A1 (en) | 2006-04-13 |
| US7381705B2 (en) | 2008-06-03 |
| US20080241156A1 (en) | 2008-10-02 |
| EP1797112A2 (en) | 2007-06-20 |
| WO2006039326A3 (en) | 2007-05-10 |
| DE602005022463D1 (de) | 2010-09-02 |
| PT1797112E (pt) | 2010-10-25 |
| CA2582095A1 (en) | 2006-04-13 |
| JP4980915B2 (ja) | 2012-07-18 |
| ES2349153T3 (es) | 2010-12-28 |
| WO2006039326A2 (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700243A1 (ru) | Способы лечения гепатита с | |
| IS7533A (is) | Lifrarbólgu C-veirutálmar | |
| ATE481106T1 (de) | Heterocyclische sulfonamid-hepatitis-c-virus- hemmer | |
| EA200801050A1 (ru) | Соединения и способы ингибирования репликации вирусного гепатита с | |
| ZA200805304B (en) | Anti-viral compounds | |
| WO2010047830A3 (en) | Agents for hcv treatment | |
| ATE413411T1 (de) | Substituierte cycloalkyl p1' hepatitis c virus inhibitoren | |
| PL1797112T3 (pl) | Inhibitory wirusa zapalenia wątroby typu C | |
| EA200501689A1 (ru) | Соединения в качестве ингибиторов вируса гепатита c | |
| DE602006015861D1 (de) | Antivirale verbindungen | |
| NO20090453L (no) | Hepatitt C Virusinhibitorer | |
| WO2008017692A3 (en) | Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition | |
| EA201170353A1 (ru) | Антитела против гепатита с и их применение | |
| MA32634B1 (fr) | Polytherapie destinee a traiter une infection par le vhc | |
| WO2009014216A1 (ja) | Ｃ型肝炎ウイルス（hcv）に対して感染阻害活性を有する抗体およびその用途 | |
| WO2005002501A3 (en) | Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same | |
| WO2004044220A3 (en) | Flaviviris fusion inhibitors | |
| Gao et al. | HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4+ Th1 cell responses in vivo | |
| DK1417233T3 (da) | Humant rekombinant antistof mod det hepatitis C (HCV) ikke-strukturelle NS3-protein, nukleinsyre og anvendelser deraf | |
| ATE521640T1 (de) | Anti-tsg101-antikörper und ihre verwendungen bei der behandlung von virusinfektionen | |
| TR200202169T1 (tr) | Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri. | |
| ATE409705T1 (de) | Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs | |
| KR100373919B1 (ko) | C형 간염 바이러스 단백질 분해 효소의 개선된 정제방법 | |
| WO2006088664A3 (en) | Flavivirus ns5a proteins for the treatment of hiv | |
| Liao et al. | The identification of three sizes of core proteins during the establishment of persistent hepatitis C virus infection in vitro |